MicroRNAs as cancer players: Potential clinical and biological effects

被引:57
|
作者
Bandres, Eva
Agirre, Xabier
Ramirez, Natalia
Zarate, Ruth
Garcia-Foncillas, Jesus
机构
[1] Univ Navarra, CIMA, Lab Pharmacogenom, Ctr Appl Med Res, E-31080 Pamplona, Spain
[2] Univ Navarra, Ctr Appl Med Res, Div Canc, Area Cell Therapy, E-31080 Pamplona, Spain
[3] Univ Navarra, Ctr Appl Med Res, Div Canc, Hematol Serv, E-31080 Pamplona, Spain
关键词
D O I
10.1089/dna.2006.0544
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MicroRNAs (miRNAs) are nonprotein-coding RNAs that function as posttranscriptional gene regulators. They can regulate their targets directly by mRNA cleavage or by repressing their translation, depending on the degree of complementariety between the miRNA and the target. Recent evidences have shown that miRNA control cell growth, apoptosis, and differentiation. Moreover, miRNA expression correlates with cancers and could have a crucial function in tumor progression. Bioinformatic data indicates that each miRNA can control hundreds of target genes, but identification of the accurate miRNA targets will be crucial to exploit the emerging knowledge of miRNA contribution to cancer process. While the miRNA field is still emerging, the benefit of our understanding of miRNA in cancer is potentially enormous, especially if we are able to apply this knowledge to provide new therapies for patients.
引用
收藏
页码:273 / 282
页数:10
相关论文
共 50 条
  • [31] The clinical potential of circulating microRNAs in obesity
    Chenbo Ji
    Xirong Guo
    Nature Reviews Endocrinology, 2019, 15 : 731 - 743
  • [32] MicroRNAs Clinical trials and potential applications
    Kalariya, Nilesh
    Brassil, Kelly
    Calin, George
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2017, 21 (05) : 554 - +
  • [33] Clinical Applications for microRNAs in Cancer
    Nana-Sinkam, S. P.
    Croce, C. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 (01) : 98 - 104
  • [34] The clinical potential of circulating microRNAs in obesity
    Ji, Chenbo
    Guo, Xirong
    NATURE REVIEWS ENDOCRINOLOGY, 2019, 15 (12) : 731 - 743
  • [35] Clinical implications of microRNAs in cancer
    Bovell, L. C.
    Putcha, B. D. K.
    Samuel, T.
    Manne, U.
    BIOTECHNIC & HISTOCHEMISTRY, 2013, 88 (07) : 388 - 396
  • [36] Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients
    Du, Mulong
    Liu, Sang
    Gu, Dongying
    Wang, Qiaoyan
    Zhu, Lingjun
    Kang, Meiyun
    Shi, Danni
    Chu, Haiyan
    Tong, Na
    Chen, Jinfei
    Adams, Tamara S.
    Zhang, Zhengdong
    Wang, Meilin
    CARCINOGENESIS, 2014, 35 (12) : 2723 - 2730
  • [37] MicroRNAs as lung cancer biomarkers and key players in lung carcinogenesis
    Vannini, Ivan
    Fanini, Francesca
    Fabbri, Muller
    CLINICAL BIOCHEMISTRY, 2013, 46 (10-11) : 918 - 925
  • [38] MicroRNAs: key players of taxane resistance and their therapeutic potential in human cancers
    Cui, Shi-Yun
    Wang, Rui
    Chen, Long-Bang
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2013, 17 (10) : 1207 - 1217
  • [39] MicroRNAs regulating Wnt signaling pathway in colorectal cancer: biological implications and clinical potentials
    Beni, Faeze Ahmadi
    Kazemi, Mohammad
    Dianat-Moghadam, Hassan
    Behjati, Mohadeseh
    FUNCTIONAL & INTEGRATIVE GENOMICS, 2022, 22 (06) : 1073 - 1088
  • [40] MicroRNAs: Important Players in Breast Cancer Angiogenesis and Therapeutic Targets
    Hussen, Bashdar Mahmud
    Abdullah, Sara Tharwat
    Rasul, Mohammed Fatih
    Salihi, Abbas
    Ghafouri-Fard, Soudeh
    Hidayat, Hazha Jamal
    Taheri, Mohammad
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8